ARTICLE | Company News
MediciNova, Zhejiang Medicine deal
July 11, 2011 7:00 AM UTC
MediciNova and Zhejiang finalized a deal and formed a JV to develop and commercialize MediciNova's MN-221 in China. The JV, named Zhejiang Sunmy Medicine Biotechnology Corp. Ltd., plans to submit an IND in China by year end for MN-221 to treat asthma (see BioCentury, March 14). ...